Osteopenia in young adult survivors of childhood cancer

Medical and Pediatric Oncology

Volumn 32, Issue 4, 1999, Pages 272-278

  Vassilopoulou Sellin, Rena ^a,c   Brosnan, Patrick ^b   Delpassand, Abraham ^a   Zietz, Hallie ^a   Klein, Mary J ^a   Jaffe, Norman ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Childhood cancer; Late effects; Osteopenia

Indexed keywords

ADAPTATION; ADOLESCENT; ADULT; AGING; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BONE MASS; BONE MINERAL; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; LIFE EXPECTANCY; MALE; MALIGNANT NEOPLASTIC DISEASE; OSTEOPENIA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BONE DENSITY; BONE DISEASES, METABOLIC; CHILD; CHILD, PRESCHOOL; FEMALE; HIP; HUMANS; INFANT; LUMBAR VERTEBRAE; MALE; MEDICAL RECORDS; NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 0033014367     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199904)32:4<272::AID-MPO6>3.0.CO;2-G     Document Type: Article

References (39)

1. Bleyer AW. The impact of childhood cancer on the United States and the world. CA Cancer J Clin 1990;40:355-367.
2. Neyssa M. Long-term survivors of childhood cancer: the medical consequences of cure. Pediatr Clin North Am 1997;44:1021-1042.
3. Meadows AT, Hobbie WL. The medical consequences of cure. Cancer 1986;58:524-529.
4. Ried H, Zietz H, Jaffe N. Late effects of cancer treatment in children. Pediatr Dent 1995;4:273-284.
5. Neglia JP, Nesbit ME. Care and treatment of long-term survivors of childhood cancer. Cancer 1993;71:3386-3391.
6. Raymond CA. Fate of childhood cancer survivors comes under increasing scrutiny. JAMA 1988;260:3246-3247.
7. Baker F. Specific health concerns of cancer survivors. Proceedings of the 10th International Symposium of Supportive Care in Cancer. San Antonio, TX, March 14-17, 1998.
8. Loge JH, Abrahamsen AF, Ekeberg O, et al. Psychological distress after cancer cure: a survey of 459 Hodgkin's disease survivors. Bri J Cancer 1997;76:791-796.
9. Hays DM, Landsverk J, Sallan SE, et al. Educational, occupational, and insurance status of childhood cancer survivors in their fourth and fifth decades of life. J Clin Oncol 1992;10:1397-1406.
10. Witherspoon RP, Fisher LD, Schoch G, et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989;321:784-789.
11. Beaty O III, Hudson MM, Greenwald C, et al. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol 1995;13:603-609.
12. Salloum E, Doria R, Schubert W, et al. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. J Clin Oncol 1996;14: 2435-2443.
13. Raney B, Heyor R, Hays DM, et al. Sequelae of treatment in 109 patients followed for 5-15 years after diagnosis of sarcoma of the bladder and prostate: report from the Intergroup Rhabdomyosarcoma Study (IRS) committee. Cancer 1993;71:2387-2394.
14. Shalet SM. Disorders of the endocrine system due to radiation and cytotoxic chemotherapy. Clin Endocrinol 1983;18:637-659.
15. Meistrich ML, Vassilopoulou-Sellin R, Lipshultz LI. Adverse effects of treatment: gonadal dysfunction. In: De Vita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of Oncology, 5th ed. Philadelphia: Lippincott-Raven; 1997. p 2758-2773.
16. Krischer JP, Epstein S, Cuthbertson DD. et al. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J Clin Oncol 1997;15: 1544-1552.
17. Hudson MM, Jones D, Boyett J, et al. Late mortality of long-term survivors of childhood cancer. J Clin Oncol 1997;15:2205-2213.
18. Tucker MA, D'Angio GJ, Boice JD, et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 1987;317:588-593.
19. Halton J, Atkinson SA, Fraher L, et al. Bone mass and mineral status at diagnosis in children with acute lymphoblastic leukemia. J Bone Min Res 1996;11:1774-1783.
20. Kaste SC, Hudson MM, Jones-Wallace D, et al. Bone mineral density in Survivors of childhood ALL. Proceedings of Research Issues in Cancer Survivorship, Bethesda, MD, March 9-10, 1998.
21. Vassilopoulou-Sellin R, Ramirez I. Severe osteopenia and vertebral compression fractures after complete remission in an adolescent with acute leukemia. Am J Hematol 1992;39:142-143.
22. D'Angelo P, Conter V, Di Chiara G, et al. Severe osteoporosis and multiple vertebral collapses in a child during treatment for B-ALL: case report. Acta Haematol 1993;89:38-42.
23. Mithal NP, Almond MK, Evans K, et al. Reduced bone mineral density in long term survivors of medulloblastoma. J Radiol 1993; 66:814-816.
24. Gilsanz V, Carlson ME, Roe TF, et al. Osteoporosis after cranial irradiation for acute lymphoblastic leukemia. J Pediatr 1990;117: 238-244.
25. Carter Dr, Bouxsein ML, Marcus R. New approaches for interpreting projected bone densitometry data. J Bone Min Res 1992; 7:137-145.
26. Ettinger B, Sidney S, Cummings SR, et al. Racial differences in bone density between young adult black and white subjects persist after adjustment for anthropometric, lifestyle, and biochemical differences. J Clin Endocrinol Metab 1997;82:429-434.
27. Slemenda CW, Miller JZ, Hui SL, et al. Role of physical activity in the development of skeletal mass in children. J Bone Min Res 1991;6:1227-1233.
28. Matkovic V, Jelic T, Wardlaw GM, et al. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoperosis. J Clin Invest 1994;93:799-808.
29. Carrie Fassler A-L, Bonjour J-P. Osteoporosis as pediatric problem. Pediatr Clin North Am 1995;42:811-824.
30. Sheth RD, Hobbs GR, Riggs JE, et al. Bone mineral density in geographically diverse adolescent population. Pediatrics 1996;98: 948-951.
31. Holmes SJ, Shalet SM. Role of growth hormone and sex steroids in achieving and maintaining normal bone mass. Horm Res 1996; 45:86-93.
32. Dhuper S, Warren MP, Brooks-Gunn J, et al. Effects of hormonal status on bone density in adolescent girls. J Clin Endocrinol Metab 1990;71:1083-1088.
33. De Boer H, Blok GJ, Van Lingen A, et al. Consequences of childhood-onset growth hormone deficiency for adult bone mass. J Bone Min Res 1994;9:1319-1326.
34. Hyer SL, Rodin DA, Tobias JH, et al. Growth hormone deficiency during puberty reduces adult bone mineral density. Arch Dis Child 1992;67:1472-1474.
35. Lukert BP. Glucocorticoid and drug-induced osteoporosis. In: Favus MJ, editor. Primer on the metabolic bone disease and disorder of mineral metabolism, 3rd ed. Philadelphia: Lippincott-Raven; 1996. p 278-282.
36. Nesbit M, Krivit W, Heyn R, et al. Acute and chronic effects of methotrexate on hepatic, pulmonary, and skeletal systems. Cancer 1976;37(suppl):1048-1054.
37. Schepper de J, Hachimi-Idrissi S, Louis O, et al. Bone metabolism and mineralisation after cytotoxic chemotherapy including ifosfamide. Arch Dis Child 1994;71:346-348.
38. Keiholz U, Max R, Scheibernbogen C, et al. Endocrine function and bone metabolism 5 years after autologus bone marrow/blood-derived progenitor cell transplantation. Cancer 1997;79:1617-1622.
39. Henderson RC, Madsen CD, Davis C, et al. Bone density in survivors of childhood malignancies. Pediatr Hematol Oncol 1996; 18:367-371.